...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Honokiol regulates mitochondrial substrate utilization and cellular fatty acid metabolism in diabetic mice heart
【24h】

Honokiol regulates mitochondrial substrate utilization and cellular fatty acid metabolism in diabetic mice heart

机译:Honokiol在糖尿病小鼠心脏中调节线粒体底物利用和细胞脂肪酸代谢

获取原文
获取原文并翻译 | 示例
           

摘要

Type 2 diabetes mellitus is strongly associated with cardiac mitochondrial dysfunction, which is one of the main reasons for cardiovascular diseases. Among the mitochondrial metabolic changes, fatty acid metabolism is of great importance as cardiac tissues depend primarily on fatty acids. Honokiol, a constituent of Magnolia tree bark extract, is reported to strongly influence cardiac mitochondrial functions, via various mechanisms. The current study showed that honokiol decreased fatty acid-mediated complex I respiration and increased carbohydrate-mediated complex I and II respiration in diabetic C57BL/6 mice cardiac mitochondria. It was also found that honokiol treatment decreased expression of Cluster of Differentiation 36, AMP-activated kinases and nuclear transcription factors like, Peroxisome proliferator-activated receptor. co-activator 1 alpha/beta and Peroxisome proliferator-activated receptor a, surrogating the evidence of decreased fatty acid-mediated complex I respiration. Honokiol treatment also reduced the levels of mitochondrial acetylated proteins, suggesting the possible action of honokiol via acetylation/deacetylation mechanism of regulation of protein functions in diabetic mitochondria. The antioxidant effect of honokiol is evidenced by the augmented expression of Manganese super oxide dismutase. In conclusion, honokiol imparts beneficial effect on diabetic cardiac mitochondria by decreasing the oxidant burden via regulating mitochondrial fatty acid respiration and expression of oxidant response factors.
机译:2型糖尿病与心脏线粒体功能障碍密切相关,线粒体功能障碍是心血管疾病的主要原因之一。在线粒体代谢变化中,脂肪酸代谢非常重要,因为心脏组织主要依赖脂肪酸。据报道,厚朴树皮提取物中的和厚朴酚通过多种机制强烈影响心脏线粒体功能。目前的研究表明,和厚朴酚降低了糖尿病C57BL/6小鼠心肌线粒体中脂肪酸介导的复合物I呼吸,增加了碳水化合物介导的复合物I和II呼吸。研究还发现,和厚朴酚治疗降低了分化簇36、AMP激活激酶和过氧化物酶体增殖物激活受体等核转录因子的表达。共激活剂1α/β和过氧化物酶体增殖物激活受体a,替代脂肪酸介导的复合物I呼吸减少的证据。和厚朴酚治疗还降低了线粒体乙酰化蛋白的水平,表明和厚朴酚可能通过乙酰化/脱乙酰化机制调节糖尿病线粒体的蛋白质功能。和厚朴酚的抗氧化作用可以通过锰超氧化物歧化酶的表达增强来证明。总之,和厚朴酚通过调节线粒体脂肪酸呼吸和氧化反应因子的表达,降低氧化剂负荷,从而对糖尿病心肌线粒体产生有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号